Article Details

Elicio Therapeutics Announces Initiation of Its Phase 1/2 Dose-Escalation Study of ELI-002 ...

Retrieved on: 2021-06-29 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Elicio Therapeutics Announces Initiation of Its Phase 1/2 Dose-Escalation Study of ELI-002 .... View article details on HISWAI: https://www.globenewswire.com/news-release/2021/06/29/2254690/0/en/Elicio-Therapeutics-Announces-Initiation-of-Its-Phase-1-2-Dose-Escalation-Study-of-ELI-002-AMPLIFY-201-in-KRAS-Driven-Cancers.html

Excerpt

... of the immune system, may stimulate an enhanced immune response.” ... of Hope, Washington University St. Louis, and Henry Ford Health System.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up